Carlit (4275) investor relations material

Executive summary

• Nine-month net sales decreased 1.5% year-over-year to ¥26,945 million, but operating profit rose 35.0% to ¥2,588 million and profit attributable to owners of parent increased 54.0% to ¥2,254 million, driven by strong performance in several segments and cost control efforts.

• Comprehensive income nearly doubled year-over-year, reaching ¥3,954 million, reflecting improved profitability and valuation gains.

• The company is in the "Investment Promotion" stage of its medium-term plan, focusing on growth in priority areas such as ammonium perchlorate and new business development.

Financial highlights

• Net sales for the nine months ended December 31, 2025, were ¥26,945 million, down 1.5% year-over-year.

• Operating profit increased 35.0% to ¥2,588 million; ordinary profit rose 29.9% to ¥2,860 million.

• Profit attributable to owners of parent was ¥2,254 million, up 54.0% year-over-year.

• Basic earnings per share for the period were ¥98.33, compared to ¥62.12 in the prior year.

• Comprehensive income surged 98.3% to ¥3,954 million.

Outlook and guidance

• Full-year forecast for FY ending March 31, 2026: net sales ¥38,000 million (+2.9% YoY), operating profit ¥3,500 million (+14.9%), ordinary profit ¥3,700 million (+11.4%), profit attributable to owners of parent ¥2,850 million (+10.9%), and basic EPS ¥125.25.

• No revisions to previously announced forecasts.

• The Chemical Products segment is expected to remain solid, but Silicon wafers will continue to face operating rate declines due to inventory adjustments.